The Effect of Treating Herpes Zoster With Oral Acyclovir in Preventing Postherpetic Neuralgia
- 28 April 1997
- journal article
- review article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 157 (8) , 909-912
- https://doi.org/10.1001/archinte.1997.00440290095010
Abstract
Research from JAMA Internal Medicine — The Effect of Treating Herpes Zoster With Oral Acyclovir in Preventing Postherpetic Neuralgia — A Meta-analysisThis publication has 21 references indexed in Scilit:
- Postherpetic Neuralgia — Pathogenesis, Treatment, and PreventionNew England Journal of Medicine, 1996
- Shingles in one family practiceArchives of Family Medicine, 1996
- Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patientsInternational Journal of Antimicrobial Agents, 1994
- New antivirals with activity against varicella-zoster virusAnnals of Neurology, 1994
- A Randomized Trial of Acyclovir for 7 Days or 21 Days with and without Prednisolone for Treatment of Acute Herpes ZosterNew England Journal of Medicine, 1994
- A retrospective and an observational study with acyclovirJournal of Medical Virology, 1993
- Lack of effect of acyclovir on postherpetic neuralgia.BMJ, 1989
- Oral acyclovir for herpes zoster: a double-blind controlled trial in normal subjectsBritish Journal of Dermatology, 1987
- High-dose intravenous acyclovir in the treatment of zoster: A double-blind, placebo-controlled trialJournal of Infection, 1983
- Intravenous acyclovir in acute herpes zoster infectionJournal of Infection, 1983